Alligator Bioscience AB (FRA:7AL0) EPS (Basic): €-0.08 (TTM As of Mar. 2026)

What is Alligator Bioscience AB EPS (Basic)?

Alligator Bioscience AB FRA:7AL0 39 EPS (Basic) is €-0.08 as of Mar. 2026. GuruFocus rates FRA:7AL0 with a GF Score™ of 39/100. The stock has 7 warning signs investors should review.

Alligator Bioscience AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.08.

Alligator Bioscience AB's EPS (Diluted) for the three months ended in Mar. 2026 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.08.

Alligator Bioscience AB's EPS without NRI for the three months ended in Mar. 2026 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.09.

During the past 3 years, the average EPS without NRI Growth Rate was 45.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 38.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Alligator Bioscience AB's highest 3-Year average EPS without NRI Growth Rate was 45.80% per year. The lowest was -89.50% per year. And the median was 12.10% per year.

Alligator Bioscience AB (FRA:7AL0) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Alligator Bioscience AB EPS (Basic) Related Terms

Alligator Bioscience AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Alligator Bioscience AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB EPS (Basic) Chart

Alligator Bioscience AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-3.83

-3.29

-2.02

-0.67

-0.17

Alligator Bioscience AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-0.05	-0.00	-0.02	-0.06	0.00

39GF Score

Alligator Bioscience AB FRA:7AL0

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Alligator Bioscience AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Alligator Bioscience AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4.719	-	0)	/	27.527
	=	-0.17

Alligator Bioscience AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.134	-	0)	/	543.574
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.08

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €-0.08 mean?

Alligator Bioscience AB (FRA:7AL0) has a EPS (Basic) of €-0.08 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Alligator Bioscience AB and its competitors.

Is Alligator Bioscience AB's EPS (Basic) too high?

Alligator Bioscience AB's current EPS (Basic) is €-0.08. Overall, Alligator Bioscience AB has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.

How does Alligator Bioscience AB's EPS (Basic) compare to VRTX and REGN?

Alligator Bioscience AB's EPS (Basic) of €-0.08 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Biotechnology company?

A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Alligator Bioscience AB and its competitors. Alligator Bioscience AB's current EPS (Basic) is €-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Alligator Bioscience AB stock overvalued right now?

Alligator Bioscience AB (FRA:7AL0) has a current EPS (Basic) of €-0.08. The current EPS (Basic) is €-0.08. Alligator Bioscience AB's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Alligator Bioscience AB (FRA:7AL0), the current EPS (Basic) is €-0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alligator Bioscience AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:SIMRIS B OSTO:NXTCL XSAT:ABERA OSTO:ELIC NGM:GTAB B OSTO:BIOVIC B OSTO:DMYD B OSTO:IRLAB A OSTO:ALZCUR OSTO:ANNX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ATORX:Sweden 0RK9:UK

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website https://www.alligatorbioscience.se

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. The company's main drug candidate, mitazalimab, is currently under development as a therapy for metastatic pancreatic cancer patients. Its development pipeline also comprises: ATOR-4066, a bispecific antibody targeting CD40, as well as CEACAM5 (carcinoembryonic antigen 5), a protein found in certain tumors; and certain externally developed programs like HLX22 and ALG.APV-527. Geographically, the company generates maximum revenue from Belgium (mainly through out-licensing), and also has its presence in Sweden and Finland.

39GF Score

Get the complete analysis for FRA:7AL0

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00

Price

View FRA:7AL0 Analysis

See EPS (Basic) data for all stocks →